Avecho licenses TPM for use in cancer drugs
Released 21 May 23
Latest announcements
Ask a question
Your question will be sent privately to Avecho Biotechnology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Avecho Biotechnology a question about this announcement.